Target intelligence / Profile preview

Coagulation Factor X (FX)

Target
FX
Molecular classification
Serine endopeptidase, Glycoprotein, Enzyme
01

Overview

Coagulation Factor X, also known as Stuart factor, is a vitamin K-dependent serine endopeptidase that plays a central role in the blood coagulation cascade. It is synthesized in the liver and circulates in plasma as an inactive zymogen. Activation to factor Xa occurs through both intrinsic and extrinsic pathways, leading to thrombin generation and fibrin clot formation. Deficiency can cause bleeding disorders, while its dysregulation is implicated in thrombotic conditions. Therapeutic interventions include Factor X concentrates to supplement deficient levels and anticoagulant drugs to inhibit its activity.

Other names
Factor XStuart factorStuart-Prower factor
02

Mechanism of action

Factor X is activated to factor Xa, which then associates with cofactor Va to form the prothrombinase complex, converting prothrombin into thrombin, an essential step for fibrin clot formation. Some drugs directly or indirectly inhibit Factor Xa activity, preventing thrombin formation and subsequent clot formation. Factor X concentrates directly supplement Factor X levels, restoring the coagulation cascade.

03

Biological functions

Blood coagulationThrombin generationHemostasis
04

Disease associations

Bleeding disorders (Factor X deficiency)ThrombosisLiver diseaseSystemic amyloidosis
05

Safety considerations

Thrombotic events (with Factor X concentrates)Bleeding (with Factor X inhibitors)Risk of infection (with plasma-derived products)Hypersensitivity reactions
06

Interacting drugs

Warfarin

1 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (APTT)Factor X activity assay

Beyond the preview

Go deeper on Coagulation Factor X (FX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation Factor X (FX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call